These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32274109)

  • 1. Calcification of coronary arteries and aortic valve and circulating a-klotho levels in patients with chronic kidney disease.
    Savvoulidis P; Kalogeropoulos AP; Raptis V; Rafailidis V; Georgianos PI; Balaskas EV; Kouskouras K; Karvounis H; Hadjimiltiades S
    J Thorac Dis; 2020 Mar; 12(3):431-437. PubMed ID: 32274109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease.
    Di Lullo L; Gorini A; Bellasi A; Morrone LF; Rivera R; Russo L; Santoboni A; Russo D
    Clin Kidney J; 2015 Dec; 8(6):732-6. PubMed ID: 26613033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease.
    Chen Y; Chen YX; Huang C; Duan ZB; Xu CY
    Int J Gen Med; 2021; 14():857-866. PubMed ID: 33758533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Serum Indoxyl Sulfate and Klotho Protein and Vascular Calcification in Patients with Chronic Kidney Disease Stages 3-5.
    Gao Y; Zhao CJ; Liu Q; Li CC; Li Z; Li J; Wang Q; Zhang L
    Int J Endocrinol; 2024; 2024():8229604. PubMed ID: 38385060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.
    Li F; Yao Q; Ao L; Cleveland JC; Dong N; Fullerton DA; Meng X
    J Mol Med (Berl); 2017 Jul; 95(7):739-751. PubMed ID: 28332126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2-5D].
    Milovanova LY; Lysenko Kozlovskaya LV; Milovanova SY; Taranova MV; Kozlov VV; Reshetnikov VA; Lebedeva MV; Androsova TV; Zubacheva DO; Chebotareva NV
    Ter Arkh; 2020 Jul; 92(6):37-45. PubMed ID: 33346491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.
    Kitagawa M; Sugiyama H; Morinaga H; Inoue T; Takiue K; Ogawa A; Yamanari T; Kikumoto Y; Uchida HA; Kitamura S; Maeshima Y; Nakamura K; Ito H; Makino H
    PLoS One; 2013; 8(2):e56695. PubMed ID: 23431388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decreased Serum Levels of Klotho Protein in Chronic Kidney Disease Patients: Clinical Imortance].
    Milovanova LY; Mukhin NA; Kozlovskaya LV; Milovanov YS; Kiyakbaev GG; Rogova IV; Lebedeva MV; Androsova TV; Milovanova SY; Gil AY; Taranova MV
    Vestn Ross Akad Med Nauk; 2016; 71(4):288-96. PubMed ID: 29297646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
    Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
    Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort.
    Tangri N; Alam A; Wooten EC; Huggins GS
    Nephrol Dial Transplant; 2011 Dec; 26(12):3998-4002. PubMed ID: 21565945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
    Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
    Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats.
    Shi YC; Lu WW; Hou YL; Fu K; Gan F; Cheng SJ; Wang SP; Qi YF; Liu JH
    Chin Med J (Engl); 2018 Mar; 131(5):532-538. PubMed ID: 29483386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
    Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
    J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Klotho is associated with cardiovascular and all-cause mortality in patients with stage 3b and 4 chronic kidney disease (CKD): a long-term prospective cohort study.
    Milovanova LY; Nezhdanov KS; Milovanova SY; Lebedeva MV; Beketov VD; Volkov AV; Kamyshova ES; Suvorov AY; Moiseev SV
    J Nephrol; 2024 Sep; ():. PubMed ID: 39223354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim MJ; Lee DW; Lee SB; Shin MJ; Rhee H; Yang BY; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2015 Dec; 19(6):1090-7. PubMed ID: 25757535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble Klotho is inversely related to coronary artery calcification assessed by intravascular ultrasound in patients with stable coronary artery disease.
    Koga S; Ikeda S; Akashi R; Yonekura T; Kawano H; Maemura K
    J Cardiol; 2021 Jun; 77(6):583-589. PubMed ID: 33303310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.